EP
ADAP

Eversept Partners’s Adaptimmune Therapeutics ADAP Stock Holding History

Eversept Partners’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-237,086
Closed -$488K – 66
2022
Q1 		$488K Sell
237,086
-111,630
-32% -$230K 0.04% 67
2021
Q4 		$1.31M Sell
348,716
-96,171
-22% -$361K 0.08% 70
2021
Q3 		$2.3M Buy
+444,887
New +$2.3M 0.16% 61